查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594008

醫療設備報銷市場：按付款人、最終用戶分類 - 2025-2030 年全球預測

Medical Devices Reimbursement Market by Payer (Private, Public), End-User (Hospitals, Outpatient Facilities) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫療設備報銷市場價值為6,331.3億美元，預計2024年將達到6,980.7億美元，複合年成長率為10.74%，到2030年將達到12933.5億美元。

醫療設備報銷的範圍和定義包括醫療保健支付者（包括保險公司和政府醫療計劃）對醫療設備的經濟補償和支付流程。這種報銷對於確保患者能夠獲得所需的技術而不會造成過度的經濟負擔至關重要。醫療設備報銷的需求源自於開發和實施先進醫療技術的高昂成本，許多患者在沒有經濟干預的情況下無法獲得這些技術。醫療設備報銷申請涵蓋心臟病學、整形外科和腫瘤學等多個醫療領域，為診斷、治療和監測提供了重要工具。最終用途主要是醫院、診所和家庭保健。主要成長要素包括全球人口老化、慢性病增加以及醫療設備技術進步，這些都推動了需求。有利於創新解決方案報銷的監管政策進一步增強了市場潛力。遠端醫療設備和人工智慧診斷等數位醫療技術存在新的機遇，醫療保健系統擴大為這些創​​新分配預算。然而，複雜的報銷流程、不一致的付款人政策以及需要大量資料來證明成本效益等挑戰限制了市場的成長。此外，不同地區的法規和經濟限制也對市場進入和擴張造成了障礙。為了克服這些挑戰，公司必須專注於使產品開發與付款人需求保持一致，並投資於健康經濟學和結果研究（HEOR）以證明其設備的價值提案。高成長的創新和研究領域包括利用基因組學和生物技術的個人化醫療以及在物聯網框架內運行的互聯醫療設備，這些設備可以簡化患者監測並改善結果。市場的適應性是高度競爭的，受政策和技術趨勢的影響很大，需要策略規劃和對監管和支付條件的持續回應。

主要市場統計
基準年[2023] 6331.3億美元
預測年份 [2024] 6980.7億美元
預測年份 [2030] 1,293,350 百萬美元
複合年成長率（%） 10.74%

市場動態：揭示快速發展的醫療設備報銷市場的關鍵市場洞察

醫療設備報銷市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病盛行率上升
    • 電子健康記錄技術發展
    • 消費者對健康保險覆蓋範圍的認知不斷增強
  • 市場限制因素
    • 贖回成本高
  • 市場機會
    • 介紹具有報銷設施的先進醫療設備
    • 政府支持醫療設備報銷的舉措
  • 市場挑戰
    • 對多個監管機構和醫療設備認證流程漫長的擔憂

波特五力：駕馭醫療設備報銷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療設備報銷市場的外部影響

外部宏觀環境因素對醫療設備報銷市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫療設備報銷市場的競爭格局

醫療設備報銷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV醫療設備報銷市場定位矩陣供應商績效評估

FPNV定位矩陣是評估醫療設備報銷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 繪製醫療設備報銷市場的成功之路

對於希望加強在全球市場的影響力的公司來說，對醫療設備報銷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病流行
      • 電子病歷技術發展
      • 意識提升
    • 抑制因素
      • 贖回成本高
    • 機會
      • 先進醫療設備介紹及保險報銷制度
      • 政府努力支持醫療設備報銷
    • 任務
      • 對醫療設備核准所需的多個監管機構和漫長流程的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章醫療設備報銷市場（依付款人分類）

  • 私人的
  • 公共

第7章醫療設備報銷市場：依最終用戶分類

  • 醫院
  • 門診設施

第8章美洲醫療設備報銷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太醫療設備報銷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲醫療設備報銷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aetna Inc.
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • CVS Health Corporation
  • Elevance Health, Inc.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • XIFIN, Inc.
Product Code: MRR-205091A88A65

The Medical Devices Reimbursement Market was valued at USD 633.13 billion in 2023, expected to reach USD 698.07 billion in 2024, and is projected to grow at a CAGR of 10.74%, to USD 1,293.35 billion by 2030.

The scope and definition of medical devices reimbursement encompass the financial coverage and payment processes for medical devices by healthcare payers, including insurance companies and government health programs. This reimbursement is crucial for ensuring patient access to necessary technologies without excessive financial burdens. The necessity of medical devices reimbursement arises from the high cost of developing and deploying advanced medical technologies, making them inaccessible for many patients without financial intervention. Its applications span across various medical disciplines such as cardiology, orthopedics, and oncology, providing critical tools for diagnosis, treatment, and monitoring. End-use scopes primarily include hospitals, clinics, and home healthcare settings. Key growth influences include the aging global population, rising prevalence of chronic diseases, and technological advancements in medical devices, which drive demand. Regulatory policies that favor reimbursement for innovative solutions further enhance market potential. Emerging opportunities exist in digital health technologies, like telemedicine devices, and AI-driven diagnostics, as healthcare systems increasingly allocate budgets for these innovations. Nonetheless, challenges such as complex reimbursement processes, inconsistent payer policies, and the need for extensive data to demonstrate cost-effectiveness limit market growth. Additionally, evolving regulations and economic constraints in different regions create barriers for market entry and expansion. To overcome these challenges, businesses should focus on aligning product development with payer requirements and invest in health economics and outcomes research (HEOR) to substantiate the value propositions of their devices. The high-growth areas of innovation and research include personalized medicine-an area capitalizing on genomics and biotechnology-and connected health devices operating within IoT frameworks, which can streamline patient monitoring and improve outcomes. The nature of the market is adaptive, competitive, and heavily influenced by policy and technology trends, calling for strategic planning and continual adjustment to regulatory and payer landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 633.13 billion
Estimated Year [2024] USD 698.07 billion
Forecast Year [2030] USD 1,293.35 billion
CAGR (%) 10.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Devices Reimbursement Market

The Medical Devices Reimbursement Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases
    • Technological developments in electronic medical records
    • Increasing consumer awareness regarding health insurance coverage
  • Market Restraints
    • High cost of reimbursement
  • Market Opportunities
    • Introduction of advanced medical devices with reimbursement facilities
    • Governmental initiatives to support medical device reimbursement
  • Market Challenges
    • Concerns related to multiple regulatory bodies and long process for approval of medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Medical Devices Reimbursement Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Devices Reimbursement Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Devices Reimbursement Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Devices Reimbursement Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Devices Reimbursement Market

A detailed market share analysis in the Medical Devices Reimbursement Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Devices Reimbursement Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Devices Reimbursement Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Devices Reimbursement Market

A strategic analysis of the Medical Devices Reimbursement Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Devices Reimbursement Market, highlighting leading vendors and their innovative profiles. These include Aetna Inc., Allianz SE, Anco Insurance, Anthem Insurance Companies, Inc., Aviva PLC, CVS Health Corporation, Elevance Health, Inc., Hamilton Leigh Ltd., HUB International Limited, Humana Inc., Medmarc Insurance Group, North American Science Associates, Inc., Reliance Nippon Life Insurance Company, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., and XIFIN, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Devices Reimbursement Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Payer, market is studied across Private and Public.
  • Based on End-User, market is studied across Hospitals and Outpatient Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases
      • 5.1.1.2. Technological developments in electronic medical records
      • 5.1.1.3. Increasing consumer awareness regarding health insurance coverage
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced medical devices with reimbursement facilities
      • 5.1.3.2. Governmental initiatives to support medical device reimbursement
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to multiple regulatory bodies and long process for approval of medical devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Devices Reimbursement Market, by Payer

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Medical Devices Reimbursement Market, by End-User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Outpatient Facilities

8. Americas Medical Devices Reimbursement Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical Devices Reimbursement Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical Devices Reimbursement Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aetna Inc.
  • 2. Allianz SE
  • 3. Anco Insurance
  • 4. Anthem Insurance Companies, Inc.
  • 5. Aviva PLC
  • 6. CVS Health Corporation
  • 7. Elevance Health, Inc.
  • 8. Hamilton Leigh Ltd.
  • 9. HUB International Limited
  • 10. Humana Inc.
  • 11. Medmarc Insurance Group
  • 12. North American Science Associates, Inc.
  • 13. Reliance Nippon Life Insurance Company
  • 14. UnitedHealth Group Incorporated
  • 15. WellCare Health Plans, Inc.
  • 16. XIFIN, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL DEVICES REIMBURSEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUTPATIENT FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2023